Pure Global
NCT05905627

Breathing Relaxation Exercise Heart Failure

The Effect of Breathing and Relaxation Exercise on Dyspnea, Fatigue and Self-Care Level
University of Yalova·ClinicalTrials.gov·behavioralCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Congestive Heart Failure
Drug/Device/Intervention
exercise
Study type
Observational
Intervention type
behavioral
Sponsor & location
Primary sponsor
University of Yalova
Location
Yalova, Turkey
Timeline & enrollment
Phase
N/A
Start date
Jun 06, 2023
End date
Jun 21, 2023
Enrollment
65 participants
Primary outcome

The effect of ephesus exercise on the mean fatigue score

Summary

The aim of the study is to determine the effect of breathing and relaxation exercises on
 dyspnea, fatigue and self-care level in heart failure patients.

ICD-10 classifications
Congestive heart failureHeart failureHypertensive heart disease with (congestive) heart failureHypertensive heart and renal disease with (congestive) heart failureHeart failure, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05905627
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05905627 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Yalova and is currently Completed. The study focuses on Congestive Heart Failure. Target enrollment is 65 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.